Market News AIOpen the app

Apimeds Pharmaceuticals says its subsidiary MindWave Innovations made two big deals with AQUAE Holdings.

DealRead the original at SEC EDGAR
Good for APUS

APUS's wholly owned MindWave signed two 12-month service deals, adding paid work. Payment includes credits, FLZH shares, and tokens whose values are unstated, and successful delivery is not assured.

APUS · Apimeds Pharmaceuticals US, Inc.

AI read · Good for APUS

The AI's read

This gives MindWave technical work through its parent company. The AQUAE deal includes service fees and ALCI Credits. The Flash deal pays partly in FLZH shares and FLASH TOKEN, whose values are not stated. Both deals last 12 months. The filing names delivery, testing, technical performance, and market acceptance risks. Still, signed service work and stated payment support APUS, even though the size of the benefit is unknown.

Get alerts for APUS

Follow Apimeds Pharmaceuticals US, Inc. (APUS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for APUS
Free on the App Store and Google Play, or on the web.